Charles is a corporate/private equity associate in our Sydney office. He advises corporations, private equity firms and their portfolio companies on a wide range of corporate matters with a focus on mergers and acquisitions in Australia and internationally.
Prior to joining Hogan Lovells, Charles worked at another international law firm both in Sydney and Singapore, where he gained significant cross-border experience. Charles completed a Bachelor of Commerce (with distinction) and a Bachelor of Laws (Honours) at Macquarie University.
Charles is admitted to practice in New South Wales, and he is currently awaiting admission to the Bar of the State of New York.
Acted for the shareholders of Menulog Group Limited in relation to the sale of their shares to UK-listed JUST EAT plc for A$855 million.*
Acted for private equity house Cinven’s Mercury Pharma Group Limited on the acquisition of pharmaceuticals businesses in Australia and Papua New Guinea.*
Acted for Right2Drive on its acquisition by ASX-listed Eclipx.*
Advised Gateway Lifestyle on its A$500 million initial public offering.*
Advised Royal Dutch Shell plc on the sale of its downstream businesses to Vitol for A$2.9 billion.*
*Matter handled prior to joining Hogan Lovells.